Caption Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
Other funds holding PTGX
Caption Management's PTGX Position: Q3 2026 in Review
Caption Management reduced its Protagonist Therapeutics (PTGX) stake by 29% in Q3 2026, selling an estimated $1.85M and leaving 32,000 shares worth $4.51M. The position accounts for 0.02% of the portfolio, ranked #698.
Caption Management first reported a position in PTGX in Q3 2021 and has held it in 12 quarters since. The position peaked at $6.59M in Q4 2021. 379 funds tracked by Wall St. Rank hold PTGX as of Q3 2026.
- Caption Management held 32,000 shares of Protagonist Therapeutics worth $4.51M as of Q3 2026.
- Caption Management sold 13,000 Protagonist Therapeutics shares in Q3 2026, an estimated $1.85M.
- Protagonist Therapeutics made up 0.02% of Caption Management's portfolio in Q3 2026, its #698 holding.
- Caption Management first reported a position in Protagonist Therapeutics in Q3 2021 and has held it in 12 quarters since.
- Caption Management's Protagonist Therapeutics position peaked at $6.59M in Q4 2021.
- 379 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q3 2026.
Based on Caption Management's 13F filing for Q3 2026, filed 16 Nov 2026.